Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045026
Filing Date
2024-11-04
Accepted
2024-11-04 16:34:01
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-20240930.htm   iXBRL 10-Q 1450344
2 EX-31.1 abcl-20240930xexx311.htm EX-31.1 10411
3 EX-31.2 abcl-20240930xexx312.htm EX-31.2 10374
4 EX-32.1 abcl-20240930xexx321.htm EX-32.1 4775
5 EX-32.2 abcl-20240930xexx322.htm EX-32.2 4752
11 abcl-20240930_g1.jpg GRAPHIC 101006
  Complete submission text file 0001628280-24-045026.txt   6193880

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20240930.xsd EX-101.SCH 39819
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abcl-20240930_cal.xml EX-101.CAL 64520
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20240930_def.xml EX-101.DEF 171037
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20240930_lab.xml EX-101.LAB 532532
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20240930_pre.xml EX-101.PRE 355809
74 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20240930_htm.xml XML 643841
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 241424119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)